Chemours Stock Price, News & Analysis (NYSE:CC)

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View CC analyst ratings or view top-rated stocks.

10 analysts have issued 1-year target prices for Chemours' stock. Their CC share price targets range from $25.00 to $43.00. On average, they predict the company's stock price to reach $33.10 in the next year. This suggests a possible upside of 11.5% from the stock's current price.
View analysts price targets for CC or view top-rated stocks among Wall Street analysts.

Chemours' stock was trading at $30.62 on January 1st, 2023. Since then, CC stock has decreased by 3.1% and is now trading at $29.68.
View the best growth stocks for 2023 here.

Chemours saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 5,410,000 shares, a decrease of 6.6% from the October 31st total of 5,790,000 shares. Based on an average trading volume of 1,190,000 shares, the days-to-cover ratio is currently 4.5 days. Currently, 3.7% of the company's stock are sold short.
View Chemours' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 8th 2024.
View our CC earnings forecast.

The Chemours Company (NYSE:CC) posted its quarterly earnings data on Thursday, October, 26th. The specialty chemicals company reported $0.64 earnings per share for the quarter, missing analysts' consensus estimates of $0.77 by $0.13. The specialty chemicals company had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.54 billion. Chemours had a positive trailing twelve-month return on equity of 42.13% and a negative net margin of 5.13%.

Chemours declared a quarterly dividend on Thursday, October 26th. Stockholders of record on Wednesday, November 15th will be paid a dividend of $0.25 per share on Friday, December 15th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.37%. The ex-dividend date is Tuesday, November 14th.
Read our dividend analysis for CC.

Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.75%.
Read our dividend analysis for CC.

ETFs with the largest weight of Chemours (NYSE:CC) stock in their portfolio include First Trust Materials AlphaDEX Fund (FXZ), First Trust Dorsey Wright Momentum & Dividend ETF (DDIV), Invesco Dorsey Wright Basic Materials Momentum ETF (PYZ), First Trust Dorsey Wright Momentum & Value ETF (DVLU), JPMorgan Active Value ETF (JAVA), Fidelity Small-Mid Cap Opportunities ETF (FSMO), iShares U.S. Basic Materials ETF (IYM) and Avantis U.S. Small Cap Value ETF (AVUV).

Chemours updated its FY 2023 earnings guidance on Friday, October, 27th. The company provided EPS guidance of $2.77-$3.00 for the period, compared to the consensus earnings per share estimate of $3.35. The company issued revenue guidance of -.

106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).

Chemours' stock is owned by a variety of retail and institutional investors. Top institutional investors include FMR LLC (11.75%), Bank of New York Mellon Corp (4.18%), Massachusetts Financial Services Co. MA (2.13%), LSV Asset Management (1.75%), Ameriprise Financial Inc. (1.74%) and Deutsche Bank AG (1.19%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott, Matthew S Abbott and Sameer Ralhan.
View institutional ownership trends.

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.